Brainstorm Cell Therapeutics
BCLI • NASDAQ
Brainstorm Cell Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Chaim Lebovits.
CEOChaim Lebovits
Next Earnings
Upcoming earnings announcement for Brainstorm Cell Therapeutics
Date
Monday, March 30, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.39
Earnings History
Past 12 earnings reports for Brainstorm Cell Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q3 2025 | -$0.19Est: -$0.37 | +48.6% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.34Est: -$0.36 | +5.6% | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.45Est: -$0.97 | +53.6% | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.51Est: -$0.27 | -88.9% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.51Est: -$0.52 | +1.9% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.60Est: -$0.45 | -33.3% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.75 | — | - | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$1.65Est: -$2.25 | +26.7% | - | — | — |
| Nov 14, 2023 | Q3 2023 | -$0.45Est: -$2.10 | +78.6% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$1.95Est: -$2.25 | +13.3% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$2.10Est: -$2.40 | +12.5% | - | — | 10-Q |
| Mar 30, 2023 | Q4 2022 | -$1.95Est: -$2.10 | +7.1% | - | — | 10-K |